Chiasmal Decussation in Oculo-Cutaneous Albinism Type 8
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.2.44 ↗Kurz gefasst
Fallbericht in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Maxence Rateaux und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department and Reference Centre for Rare Ophthalmology Diseases, (OPHTARA), ERN-Eye, University Hospital Necker-Enfants Malades, APHP, …. Hauptthemen laut MEDLINE: Albinism, Oculocutaneous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Albinism is a genetic disorder characterized by a defect in melanin biosynthesis. Ophthalmological and dermatological impairments vary according to the patient genotype and are highly heterogenous. Recently, variants in the DCT gene were showed to be responsible for a new type of oculocutaneous albinism (OCA) named OCA8. We report the ophthalmological, electrophysiological, and dermatological characteristics of three patients with genetically confirmed OCA8.
Methods
This is a retrospective study of three patients with OCA8. Complete dermatological, ophthalmological, and orthoptic examinations were performed with clinical exploration and multimodal imaging. Visual evoked potentials (VEPs) were performed to characterize chiasmal decussation in two of the three patients.
Results
The dermatological phenotype was mild, whereas all three patients exhibited infantile nystagmus syndrome with reduced visual acuity, foveal hypoplasia (grade 3), macular hypopigmentation (graded from 2 to 1), and iris transillumination (grade 3). Patients who could undergo a VEP examination exhibited signs of strong chiasmal misrouting.
Conclusions
Recently, pathogenic variants in the DCT gene were proven to cause OCA. Whereas patients with OCA8 exhibit a milder dermatological phenotype than others, their vision was initially described as impaired. The present report confirms previous findings and suggests that chiasmal misrouting is present in OCA8. This, together with recent findings in the murine model, supports the hypothesis that DCT regulates levels of L-Dopa and downstream signaling in the developing retina. These results convey critical future therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ophthalmology Department and Reference Centre for Rare Ophthalmology Diseases, (OPHTARA), ERN-Eye, University Hospital Necker-Enfants Malades, APHP, Paris, France.
- Centre Borelli, Paris Cité University, ENS Paris-Saclay, CNRS, INSERM, SSA, Paris, France.
- Dermatology Department and Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), FIMARAD, ERN-Skin, Paris Cité University, INSERM U1163, Institut Imagine, University Hospital Necker-Enfants Malades, APHP,…
- Medical Genetic Department, University Hospital of Bordeaux, Bordeaux, France.
- Rare Diseases Genetics and Metabolism, INSERM U1211, SBM Department, University of Bordeaux, Bordeaux, France.
- INSERM UMRS 1138, T17, Centre des Cordeliers, Paris Cité University, Paris, France.
Zitieren
APA
Rateaux, M., Hadj-Rabia, S., Barrois, R., Zambrowski, O., Michaud, V., Moreno-Artero, E., Bremond-Gignac, D., Javerzat, S., & Robert, M. P. (2025). Chiasmal Decussation in Oculo-Cutaneous Albinism Type 8. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.44
Vancouver
Rateaux M, Hadj-Rabia S, Barrois R, Zambrowski O, Michaud V, Moreno-Artero E, et al. Chiasmal Decussation in Oculo-Cutaneous Albinism Type 8. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.44
BibTeX
@article{Rateaux2025,
author = {Rateaux, Maxence and Hadj-Rabia, Smaïl and Barrois, Rémi and Zambrowski, Olivia and Michaud, Vincent and Moreno-Artero, Ester and Bremond-Gignac, Dominique and Javerzat, Sophie and Robert, Matthieu P},
title = {Chiasmal Decussation in Oculo-Cutaneous Albinism Type 8},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.2.44}
}
EUVIMED